Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Ritlecitinib |
| Trade Name | |
| Synonyms | PF-06651600|PF06651600|PF 06651600 |
| Drug Descriptions |
Ritlecitinib (PF-06651600) is a covalent Jak3 inhibitor, which reduces downstream signaling and potentially inhibits tumor cell viability (PMID: 35411095). |
| DrugClasses | JAK3 Inhibitor 6 |
| CAS Registry Number | 1792180-81-4 |
| NCIT ID | C161783 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Ritlecitinib | Ritlecitinib | 1 | 1 |